Filing Details
- Accession Number:
- 0001640455-19-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-16 20:59:16
- Reporting Period:
- 2019-08-14
- Accepted Time:
- 2019-08-16 20:59:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1640455 | Jounce Therapeutics Inc. | JNCE | Biological Products, (No Disgnostic Substances) (2836) | 454870634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1693456 | Elizabeth Trehu | C/O Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-08-14 | 670 | $4.10 | 60,855 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-08-15 | 648 | $4.00 | 60,207 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-08-16 | 1,018 | $3.92 | 59,189 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- Represents the weighted average share price of an aggregate total of 670 shares sold in the price range of $4.02 to $4.18 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 648 shares sold in the price range of $3.94 to $4.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 1,018 shares sold in the price range of $3.85 to $4.06 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.